Related Experiment Video

Updated: May 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

[Cardiorenal syndrome : what's new in 2026]

Capucine Bastid1, Belén Ponte2, Philippe Meyer3

  • 1Service de médecine interne aiguë de l'âgé, Département de réadaptation et gériatrie, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|May 22, 2026
PubMed

Insights

Cardiorenal syndrome involves both heart and kidney dysfunction, leading to high mortality. Understanding its complex mechanisms is crucial for effective diagnosis and treatment, especially in acute cardiac cases.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Cardiorenal syndrome (CRS) is the simultaneous dysfunction of the heart and kidneys.
  • High morbidity and mortality rates are associated with CRS.
  • CRS presents complex pathophysiological mechanisms, challenging clinical management.

Purpose of the Study:

  • To provide an updated summary of cardiorenal syndrome.
  • To highlight recent pathophysiological and clinical data.
  • To focus on acute forms of CRS in cardiology.

Main Methods:

  • Review of recent pathophysiological data.
  • Analysis of current clinical findings.
  • Focus on acute cardiorenal presentations.

Main Results:

  • CRS encompasses heterogeneous clinical situations.
  • Mechanisms of CRS are complex and often difficult to identify.
  • Recognition and understanding are essential for diagnosis and therapy.

Conclusions:

  • Updated understanding of CRS is critical.
  • Recent data aids in better diagnosis and management.
  • Focus on acute CRS is important for cardiology practice.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...